InVivoMAb Anti-Human BMP4 Antibody (6H4) from ProteoGenix; catalogue ARO-A13011; research use only.
Know who made it. See the evidence. Buy through one marketplace.
InVivoMAb Anti-Human BMP4 Antibody (6H4) is a ProteoGenix primary antibody supplied under catalogue number ARO-A13011 for research use only.
Target: Bone morphogenetic protein 4; Host: Mouse; Clonality: Monoclonal Antibody; Buffer: 0.01M PBS, pH 7.4.; Reactivity: Human.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
Bone morphogenetic protein 4 (BMP4/BMP-4) is a secreted TGF-beta superfamily growth factor involved in developmental signalling and tissue differentiation. ABMIUM catalogue products linked below support research on BMP4 biology.
Biological function: Bone morphogenetic protein 4 (BMP4) is a TGF-beta superfamily growth factor with key roles in developmental patterning, differentiation, osteogenesis and vascular development. Canonical BMP4 signalling occurs through type I and type II BMP receptors and activates SMAD1/5/8-dependent transcription, while additional non-canonical pathways can also contribute.
